These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26474842)

  • 1. Assessment of quality performance measures for primary percutaneous coronary intervention: A report from a tertiary referral centre in Switzerland.
    Haas C; Fournier S; Iglesias JF; Trana C; Roguelov C; Locca D; Lauriers N; Muller O; Eeckhout E
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):435-442. PubMed ID: 26474842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
    Harrison RW; Simon D; Miller AL; de Lemos JA; Peterson ED; Wang TY
    Am Heart J; 2016 Aug; 178():95-101. PubMed ID: 27502856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST).
    Filgueiras Filho NM; Feitosa Filho GS; Solla DJF; Argôlo FC; Guimarães PO; Paiva Filho IM; Carvalho LGM; Teixeira LS; Rios MNO; Câmara SF; Novais VO; Barbosa LS; Ballalai CS; De Lúcia CV; Granger CB; Newby LK; Lopes RD
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29980522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
    Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.
    Pandey A; Golwala H; Hall HM; Wang TY; Lu D; Xian Y; Chiswell K; Joynt KE; Goyal A; Das SR; Kumbhani D; Julien H; Fonarow GC; de Lemos JA
    JAMA Cardiol; 2017 Jul; 2(7):723-731. PubMed ID: 28445559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in evidence-based treatment and mortality for ST elevation myocardial infarction in Malaysia from 2006 to 2013: time for real change.
    Venkatason P; Zubairi YZ; Hafidz I; Wan WA; Zuhdi AS
    Ann Saudi Med; 2016; 36(3):184-9. PubMed ID: 27236389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
    Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
    J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Șerban RC; Hadadi L; Șuș I; Lakatos EK; Demjen Z; Scridon A
    Int J Cardiol; 2017 Sep; 243():437-442. PubMed ID: 28506549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcomes of patients with recurrent myocardial infarction: A prospective observational cohort study.
    Radovanovic D; Maurer L; Bertel O; Witassek F; Urban P; Stauffer JC; Pedrazzini G; Erne P
    J Cardiol; 2016 Dec; 68(6):498-503. PubMed ID: 26778745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking as a quality of care improvement tool for patients with ST-elevation myocardial infarction: an NCDR ACTION Registry experience in Latin America.
    Caixeta A; Franken M; Katz M; Lemos PA; Gomes I; Yokota PK; V Alliegro P; Pesaro EE; Neto MC; Valentine CM; Brindis RG; Makdisse M
    Int J Qual Health Care; 2020 Apr; 32(1):A1-A8. PubMed ID: 31832665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chain of survival for ST-segment elevation myocardial infarction: insights into the Middle East.
    El-Deeb MH
    Crit Pathw Cardiol; 2013 Sep; 12(3):154-60. PubMed ID: 23892947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of evidence-based management for acute coronary syndrome.
    Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
    N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome.
    Hao Y; Liu J; Liu J; Smith SC; Huo Y; Fonarow GC; Ma C; Ge J; Taubert KA; Morgan L; Guo Y; Zhang Q; Wang W; Zhao D;
    Am Heart J; 2016 Sep; 179():107-15. PubMed ID: 27595685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute coronary syndromes: clinical characteristics, management, and outcomes at the American University of Beirut Medical Center, 2002-2005.
    Abdallah M; Karrowni W; Shamseddeen W; Itani S; Kobeissi L; Ghazzal Z; Alam S; Dakik HA
    Clin Cardiol; 2010 Jan; 33(1):E6-E13. PubMed ID: 20014175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management, hospital outcome and revascularization trends in non-ST elevation myocardial infarction with high GRACE risk score.
    Akhter Z; Rind IA; Aijaz S; Sattar S; Malik R; Pathan A
    J Pak Med Assoc; 2019 Oct; 69(10):1486-1492. PubMed ID: 31622302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.